Recent Press ReleasesApply04.19.2021Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®04.19.2021Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®04.15.2021Pfizer Invites Shareholders to Attend Virtual-Only 2021 Annual Meeting of Shareholders on April 2204.12.2021Myovant Sciences and Pfizer Announce First Participant Dosed in Phase 3 SERENE Study Evaluating Contraceptive Efficacy of Once-Daily Relugolix Combination Tablet04.07.2021Pfizer Announces Extension of Review of New Drug Application of Abrocitinib for the Treatment of Moderate to Severe Atopic Dermatitis04.02.2021Pfizer Invites Public to Register for Webcast of Analyst and Investor Call to Review Oncology Business on April 9, 202104.01.2021Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study03.31.2021Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents03.26.2021EMA Approves New Storage Option for Pfizer-BioNTech Vaccine, Easing Distribution and Storage of Doses Across European Union 03.25.2021Joint FDA Advisory Committee Votes on Application for Tanezumab for the Treatment of Osteoarthritis PainMedia ContactsGet to Know UsCompany Fact SheetFeatured StoriesPodcastsPress Kits @Pfizer @Pfizer_Newsby pfizerTweets by pfizer_news
